QQ客服 官方微博 反馈留言

	The overall safety evaluation of programmed cell death/programmed cell death ligand 1 (PD-1/PD-L1) treatment for lung cancer patients An updated systematic review and meta-analysis
	Shang, Heli; Zhang, Zewen; Feng, Alei; Yang, Xiaowei; Zhang, Shuisheng; Zhao, Yi; Zhu, Qingshan; Mao, Yantao; Liu, Kun; Tian, Yuan
刊名	MEDICINE
	2019
卷号	98期号:30
关键词	lung cancer meta-analysis programmed cell death-1/programmed cell death ligand 1 safety
DOI	10.1097/MD.0000000000016439
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4549399
专题	山东大学
作者单位	Shandong First Med Univ, Hosp 1, Shandong Prov Qianfoshan Hosp, Dept Radiotherapy Oncol, 16766 Jingshi Rd, Jinan 2
推荐引用方式 GB/T 7714	Shang, Heli,Zhang, Zewen,Feng, Alei,et al. The overall safety evaluation of programmed cell death/programmed cell death ligand 1 (PD-1/PD-L1) treatment for lung cancer patients An updated systematic review and meta-analysis[J]. MEDICINE,2019,98(30).
APA	Shang, Heli.,Zhang, Zewen.,Feng, Alei.,Yang, Xiaowei.,Zhang, Shuisheng.,...&Tian, Yuan.(2019).The overall safety evaluation of programmed cell death/programmed cell death ligand 1 (PD-1/PD-L1) treatment for lung cancer patients An updated systematic review and meta-analysis.MEDICINE,98(30).
MLA	Shang, Heli,et al."The overall safety evaluation of programmed cell death/programmed cell death ligand 1 (PD-1/PD-L1) treatment for lung cancer patients An updated systematic review and meta-analysis".MEDICINE 98.30(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。